Clinical Trials Browser

Acetaminophen × 90 days × Clear all

NCT05319730 2026-05-26

MK-3475-06B

Phase 1/2 Recruiting

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05597878 2026-05-26

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Phase 2/3 Suspended

Agnosia, Prostatic Neoplasms

NCT06788912 2026-05-26

MK-3475-01E

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT07570173 2026-05-26

MK-1045-005

Phase 2/3 Recruiting

Burkitt Lymphoma

NCT06305754 2026-05-22

MK-2870-009

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03805932 2026-05-19

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Phase 1 Active not recruiting

18 enrolled 15 charts

Other hematologic neoplasm

Leukemia, Hairy Cell

NCT04165096 2026-05-13

MK-3475-01C

Phase 2 Completed

128 enrolled 14 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT06009926 2026-05-13

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

Phase 2 Active not recruiting

Other neoplasmOther solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06992427 2026-05-11

HOPE

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06824467 2026-05-08

TroFuse-022

Phase 3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06043323 2026-05-06

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular

NCT03823534 2026-04-22

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

Phase 3 Recruiting

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Pain, Pain, Postoperative

NCT05876390 2026-04-16

IRACPoP

Enrolling by invitation

Breast Neoplasms, Pain, Postoperative

NCT05088876 2026-04-13

ParOP

Phase 4 Terminated

Pain

NCT04268498 2026-03-24

ADVANCE

Phase 2 Active not recruiting

Multiple Myeloma

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Phase 1 Completed

15 enrolled 21 charts

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT02439034 2026-03-16

KETOCOL

Phase 2 Completed

GynecologicHead & Neck

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT05896228 2026-03-11

Iber-KDd

Phase 2 Recruiting

Multiple Myeloma

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections